中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Simulating androgen receptor selection in designer yeast

文献类型:期刊论文

作者Zhang, Haoran5,6,7; Zhang, Lu5,6,7; Xu, Yipeng4; Chen, Shaoyong2,3; Ma, Zhenyi1,7; Yao, Mingdong5,6,7; Li, Fangyin4; Li, Bo5,6,7; Yuan, Yingjin5,6,7
刊名SYNTHETIC AND SYSTEMS BIOTECHNOLOGY
出版日期2022-12-01
卷号7
关键词Androgen receptor mutations Androgen receptor antagonists Prostate cancer Saccharomyces cerevisiae
ISSN号2405-805X
DOI10.1016/j.synbio.2022.07.005
通讯作者Yuan, Yingjin(yjyuan@tju.edu.cn)
英文摘要Androgen receptor (AR) mutation is closely associated with prostate cancer (PCa) and is one of the mechanisms of resistance to PCa therapies such as AR antagonists. Although sequencing technologies like next-generation sequencing (NGS) contributes to the high-throughput and precise detection of AR mutations carried by PCa patients, the lack of interpretations of these clinical genetic variants has still been a roadblock for PCa-targeted precision medicine. Here, we established a designer yeast reporter assay to simulate natural androgen receptor (AR) selection using AR antagonists. Yeast HIS3 gene transactivation was associated with the ligand-induced recruitment of steroid receptor coactivator-1 (SRC-1) by AR mutants, where yeast growth in histidine-free me-dium was determined as the outcome. This assay is applicable to determine a wide range of clinical AR mutants including those with loss of function relating to androgen insensitivity syndrome (AIS), and those associated with PCa conferring resistance to AR antagonists such as enzalutamide (ENZ), bicalutamide (BIC), and cyproterone acetate (CPA). One clinical AR mutant previously reported to confer ENZ-resistance, F877L, was found to confer partial resistance to CPA as well using designer yeast. Our simple and efficient assay can enable precise one-pot screening of AR mutants, providing a reference for tailored medicine.
WOS关键词RESISTANT PROSTATE-CANCER ; STRUCTURAL BASIS ; BINDING DOMAIN ; CELL-GROWTH ; GENE ; MECHANISMS ; ENZALUTAMIDE ; ANTIANDROGEN ; BICALUTAMIDE ; MUTATIONS
资助项目National Natural Science Foundation of China[21621004] ; National Natural Science Foundation of China[31861143017]
WOS研究方向Biotechnology & Applied Microbiology
语种英语
WOS记录号WOS:000848339100001
出版者KEAI PUBLISHING LTD
资助机构National Natural Science Foundation of China
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/131926]  
专题中国科学院合肥物质科学研究院
通讯作者Yuan, Yingjin
作者单位1.Tianjin Med Univ, Sch Basic Med Sci, Tianjin 300070, Peoples R China
2.Harvard Med Sch, Boston, MA 02215 USA
3.Beth Israel Deaconess Med Ctr, Dept Med, Hematol Oncol Div, Boston, MA 02215 USA
4.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Urol, Hangzhou, Peoples R China
5.Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
6.Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China
7.Tianjin Univ, Frontier Sci Ctr Synthet Biol, Tianjin 300072, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Haoran,Zhang, Lu,Xu, Yipeng,et al. Simulating androgen receptor selection in designer yeast[J]. SYNTHETIC AND SYSTEMS BIOTECHNOLOGY,2022,7.
APA Zhang, Haoran.,Zhang, Lu.,Xu, Yipeng.,Chen, Shaoyong.,Ma, Zhenyi.,...&Yuan, Yingjin.(2022).Simulating androgen receptor selection in designer yeast.SYNTHETIC AND SYSTEMS BIOTECHNOLOGY,7.
MLA Zhang, Haoran,et al."Simulating androgen receptor selection in designer yeast".SYNTHETIC AND SYSTEMS BIOTECHNOLOGY 7(2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。